Clinical significance of CA 19-9 as a tumor marker for gynecologic malignancies
Inoue, M.; Saitoh, J.; Abe, Y.; Inoue, Y.; Ueda, G.; Tanizawa, O.; Gamoh, Y.; Dan, A.; Satoh, T.
Nihon Sanka Fujinka Gakkai Zasshi 37(11): 2411-2414
1985
ISSN/ISBN: 0300-9165 PMID: 3865972 Document Number: 250360
Document emailed within 1 workday
Related Documents
Inoue, M.; Fujita, Y.; Abe, Y.; Inoue, Y.; Ueda, G.; Tanizawa, O.; Minagawa, J.; Yamada, T.; Ohashi, K.; Ozaki, M. 1985: Tissue polypeptide antigen as a tumor marker for gynecologic malignancies Nihon Sanka Fujinka Gakkai Zasshi 37(9): 1799-1805Aoki, D.; Hirasawa, A.; Susumu, N. 2005: Diagnostic significance of tumor markers for gynecologic malignancies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(3): 411-416
Hara, K.; Mitsuhashi, F.; Ohkura, H. 1990: Clinical significance of CA 50 assay as a tumor marker Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 971-973
Kato, H. 1990: Clinical significance of SCC antigen assay as a tumor marker Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 1057-1059
Kimura, T.; Nawata, H. 1990: Clinical significance of elastase 1 assay as a tumor marker Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 899-902
Kubota, S. 1990: Clinical significance of polyamine assay as a tumor marker Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 953-956
Fujino, M.; Endo, Y. 1990: Clinical significance of carcinoembryonic antigen assay as a tumor marker Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 907-911
Endo, J.; Nagaoka, S.; Kannagi, R. 1990: Clinical significance of sialyl SSEA-1 assay as a tumor marker Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 1008-1012
Kuriyama, M.; Takahashi, Y.; Kawada, Y. 1990: Clinical significance of prostatic acid phosphatase assay as a tumor marker Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 925-927
Yamano, M. 1990: Clinical significance of des-gamma-carboxy prothrombin assay as a tumor marker Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 999-1002
Nakagawa, C.; Tsukahara, T.; Shimatake, H. 1990: Clinical significance of anti human N-myc protein antibody assay as a tumor marker Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 942-945
Avall Lundqvist, E.; Nordström, L.; Sjövall, K.; Eneroth, P. 1989: Evaluation of seven different tumour markers for the establishment of tumour marker panels in gynecologic malignancies European Journal of Gynaecological Oncology 10(6): 395-405
Kreienberg, R. 1989: General and specific laboratory parameters within the scope of tumor after-care in gynecologic malignancies and breast cancer Der Gynakologe 22(1): 55-62
Kimura, E.; Murae, M.; Koga, R.; Odawara, Y.; Nakabayashi, Y.; Yokoyama, K.; Nakata, H.; Totake, T.; Ochiai, K.; Yasuda, M. 1984: Clinical significance of new tumor marker CA 125 in gynecological cancer--particularly usefulness in diagnosis of ovarian cancer Nihon Sanka Fujinka Gakkai Zasshi 36(11): 2121-2128
Oremek, G.; Kukshaĭte, R.; Sapoutzis, N.; Ziolkowski, P. 2007: The significance of TU M2-PK tumor marker for lung cancer diagnostics Klinicheskaia Meditsina 85(7): 56-58
Usui, N. 2019: Hematologic Malignancies/Pediatric Malignancies Current Guidelines of Clinical Management and Drug Therapy for Hematological Malignancies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 46(5): 859-861
Xie, J.-w.; Huang, C.-m.; Zheng, C.-h.; Li, P.; Wang, J.-b.; Lin, J.-x.; Lu, J. 2013: Expression tumor stem cell surface marker CD44 in gastric cancer and its significance Zhonghua Wei Chang Wai Ke Za Zhi 16(11): 1107-1112
Li, Z.X. 1991: Clinical significance of the determination of cellular DNA content in gynecologic neoplasms Zhonghua Fu Chan Ke Za Zhi 26(3): 177-179
Mayer, H.O.; Burmucic, R. 1987: Anaerobic pathogens in gynecologic samples. Incidence and clinical significance Zentralblatt für Gynakologie 109(18): 1118-1125
Takahashi, M. 1984: A study on clinical significance of oncofetal antigen-1 in gynecologic tumors Nihon Sanka Fujinka Gakkai Zasshi 36(12): 2613-2618